Matrix metalloproteinases are involved in both type i (Apoptosis) and type II (Autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1335-1344

  Augustin, Sébastien ^a,b   Berard, Madeleine ^a,b   Kellaf, Sabine ^a,b   Peyri, Nicole ^a,b   Fauvel LAFÈVE, Francoise ^a,b   Legrand, Chantal ^a,b   He, Lu ^a,b   Crépin, Michel ^a,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

Apoptosis; Autophagy; MDA MB 435; MDA MB 231; Mmps

Indexed keywords

COLLAGEN TYPE 1; F ACTIN; GELATINASE B; ILOMASTAT; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PHENYLACETATE SODIUM; PHENYLACETIC ACID DERIVATIVE; PHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST TUMOR; CELL DEATH; CELL PROLIFERATION; DEPOLYMERIZATION; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; METASTASIS; NICK END LABELING; PRIORITY JOURNAL; PSEUDOPODIUM; TUMOR CELL; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; PHENYLACETATES; TUMOR CELLS, CULTURED;

EID: 64949118012     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
2. Kitanaka C, and Kuchino Y: Caspase-independent programmed cell death with necrotic morphology. Tanpakushitsu Kakusan Koso 44: 2091-2100, 1999.
3. Suzuki N, Urano J and Tamanoi F: Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells. Proc Natl Acad Sci USA 95: 15356-15361, 1998.
4. Prasanna P, Shack S, Wilson VL and Samid D: Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'- deoxycytidine-induced carcinogenesis. Clin Cancer Res 1: 865- 871,1995.
5. Samid D, Shack S and Sherman LT: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52: 1988-1992, 1992.
6. Adam L, Crepin M, Savin C and Israel L: Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7ras cells in vitro and in nude mice. Cancer Res 55: 5156-5160, 1995.
7. Chan HC, Kuo SC, Huang LJ, Liu CH and Hsu SL: A phenylacetate derivative, SCK6, inhibits cell proliferation via Gl cell cycle arrest and apoptosis. Eur J Pharmacol 467: 31-39,2003.
8. Wei MX, Liu JM, Gadal F, Yi P, Liu J and Crepin M: Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis. Anticancer Res 27: 953-958, 2007.
9. Adam L, Crepin M and Israel L: Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination. Cancer Res 57: 1023-1029, 1997.
10. Thibout D, Di Benedetto M, Kraemer M, Sainte-Catherine O, Derbin C and Crepin M: Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines. Anticancer Res 18: 2657-2661, 1998.
11. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
12. Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA and Cross-Doersen DE: Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ 7: 351-359, 1996.
13. Bachmeier BE, Nerlich AG, Lichtinghagen R and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 21: 3821-3828, 2001.
14. Tatsumi T, Shimazaki C, Goto H, Araki S, Sudo Y, Yamagata N, Ashihara E, Inaba T, Fujita N and Nakagawa M: Expression of adhesion molecules on myeloma cells. Jpn J Cancer Res 87: 837-842, 1996.
15. Shi YB, Li Q, Damjanovski S, Amano T and Ishizuya-Oka A: Regulation of apoptosis during development: input from the extracellular matrix (review). Int J Mol Med 2: 273-282, 1998.
16. Sommers CL, Byers SW, Thompson EW, Torri JA, and Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335, 1994.
17. Price JE, Polyzos A, Zhang RD and Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721, 1990.
18. Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R and Raines EW: Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ 9: 1360-1367, 2002.
19. Haas TL, Davis SJ and Madri JA: Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273: 3604-3610, 1998.
20. Biederbick A, Kern HF and Elsasser HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 66: 3-14, 1995.
21. Munafo DB and Colombo MI: A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114: 3619-3629, 2001.
22. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F and Santonastaso C: A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 216: 444-450, 1994.
23. Malherbe S, Crepin M, Legrand C and Wei MX: Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells. Anticancer Drugs 15: 975-981, 2004.
24. Seidler DC, Schaefer L, Robenek H, Iozzo RV, Kresse H and Schonherr E: A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem Biophys Res Commun 332: 1162- 1170,2005.
25. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004.
26. Yu K, Toral-Barza L, Discafani C, Zhang WG, Skotnicki J, Frost P and Gibbons JJ: mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 8: 249-258, 2001.
27. Gajewska M, Gajkowska B and Motyl T: Apoptosis and autophagy induced by TGF-B1 in bovine mammary epithelial BME-UV1 cells. J Physiol Pharmacol 56: 143-157, 2005.
28. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
29. Vasse M, Thibout D, Paysant J, Legrand E, Soria C, and Crepin M: Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules. Br J Cancer 84: 802-807, 2001.
30. Gilles C, Polette M, Seiki M, Birembaut P and Thompson EW: Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest 76: 651-660, 1997.
31. Alonso DF, Farina HG, Arregui C, Aon MA and Gomez DE: Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary- carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole. Int J Cancer 83: 242-246, 1999.
32. Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701, 2006.
33. Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, Junquera S, Merino AM and Garcia-Muniz JL: Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96: 903-911, 2007.
34. Verma RP and Hansch C: Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 15: 2223-2268, 2007.
35. Simian M, Molinolo A and Lanari C: Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression. Am J Pathol 168: 270-279, 2006.
36. Paixao-Cavalcante D, van den Berg CW, de Freitas Fernandes- Pedrosa M, Goncalves de Andrade RM and Tambourgi DV: Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by loxosceles venom sphingomyelinase D. J Invest Dermatol 126: 61-68, 2006.